Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3- Dexamethasone Administration in 1st Episode of Febrile Urinary Tract Infection Episode as Renal Damage Prevention Strategy. DEXCAR

NCT02034851 is registered in ClinicalTrials.gov with Institut Investigacio Sanitaria Pere Virgili as lead sponsor.

NCT NCT02034851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02034851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3- Dexamethasone Administration in 1st Episode of Febrile Urinary Tract Infection Episode as Renal Damage Prevention Strategy. DEXCAR
Lead sponsor
Institut Investigacio Sanitaria Pere Virgili
Phase
Observational
Overall status
Completed
Start date
April 30, 2013
Completion date
June 30, 2019
Enrollment
183 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

acute pyelonephritis